Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas
Wen-Ting Cheng,1,* Hsiu-O Ho,1,* Shyr-Yi Lin,2,3 Der-Zen Liu,4 Ling-Chun Chen,5 Ming-Thau Sheu1 1School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan, Republic of China; 2Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, T...
Main Authors: | Cheng WT, Ho HO, Lin SY, Liu DZ, Chen LC, Sheu MT |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-10-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/carfilzomib-and-paclitaxel-co-loaded-protein-nanoparticles-an-effectiv-peer-reviewed-fulltext-article-IJN |
Similar Items
-
An Untargeted Metabolomics Approach on Carfilzomib-Induced Nephrotoxicity
by: Ioanna Barla, et al.
Published: (2022-11-01) -
Carfilzomib for relapsed and refractory multiple myeloma
by: Groen K, et al.
Published: (2019-04-01) -
The use of carfilzomib to treat extramedullary plasmacytoma and review of the literature
by: Figen Atalay
Published: (2020-01-01) -
Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice
by: R. N. Alyautdin, et al.
Published: (2022-06-01) -
Evaluate the Clinical Outcome of Nanoparticle Albumin-bound Paclitaxel on Breast Cancer Treatment: A Systematic Review and Meta-analysis
by: Yasaman Shariati, et al.
Published: (2022-09-01)